Barcelona Science Park, a strategic hub for public R&D&i of excellence 15/12/2022 Healthcare Access to innovation Talento Corporate 2021 was a year full of challenges and milestones achieved for public research groups and institutes working at the... Partners - Parc Científic de Barcelona
Oxolife receives a 2.4M€ grant to develop a new treatment for infertility related to polyc... 13/12/2022 Healthcare Access to innovation Corporate Oxolife, in collaboration with Cordoba’s University, will advance from preclinical to phase II clinical trials in the... Partners - Inveready
ORYZON presents final data from Phase IIa ALICE trial in unfit AML patients with first-lin... 13/12/2022 Corporate Clinical efficacy signals were robust, with an objective response rate (ORR) of 81%; of these, 64% were complete... Partners - Oryzon Genomics
This was the Health Hackathon 2022 02/12/2022 Healthcare Corporate Last Thursday, November 24, the Ramón y Cajal Hospital in Madrid hosted the Health Hackathon 2022 Partners
PharmaMar leads the ONCOLIBERYX consortium together with four research centers to develop ... 02/12/2022 Healthcare Access to innovation Innovative drugs Financing Corporate The project, given the necessity for public-private collaboration projects, approved by the Ministry of Science and... Partners
Clément Destoumieux, CEO of medmesafe will attend the Health Hackathon 2022 23/11/2022 Healthcare Corporate On November 24, the Health Hackathon will be held at the Ramón y Cajal Hospital in Madrid Partners
‘Globolizados: Road trip’: a solidarity challenge to support associations and patients wit... 21/11/2022 Healthcare Corporate The 'Globolizados' solidarity campaign, developed by Janssen Spain with the social support of the Spanish Society of... Partners
BIOLAN Awarded as connected 4.0 SME in the IV Edition of the National Industry 4.0 Awards ... 21/11/2022 Access to innovation Corporate Estos premios reconocen el esfuerzo y el mérito de las empresas industriales españolas en el ámbito de la digitalización Partners - Biolan
Value-based medicine and Risk Sharing Agreement 16/11/2022 Healthcare Corporate We have witnessed major advances in biotechnology and synthetic biology that are likely to result in the emergence of... Partners - GENESIS Biomed
BrainEver and 3P Biopharmaceuticals collaborate on development of recombinant human homeop... 15/11/2022 Healthcare Access to innovation Corporate The novel drug could cure neurodegenerative diseases such as Amyotrophic Lateral Sclerosis Partners - 3PBIOVIAN
